Cost and Resource Utilization Associated With Fluconazole as First-Line Therapy for Invasive Candidi...
Cost and Resource Utilization Associated With Fluconazole as First-Line Therapy for Invasive Candidiasis: A Retrospective Database Analysis
About this item
Full title
Author / Creator
Publisher
Bridgewater, NJ: EM Inc USA
Journal title
Language
English
Formats
Publication information
Publisher
Bridgewater, NJ: EM Inc USA
Subjects
More information
Scope and Contents
Contents
Abstract Background Fluconazole is a standard first-line therapy for candidemia/invasive candidiasis (C/IC), based on its efficacy, safety profile, and comparatively low acquisition cost. However, little is known about the total costs associated with fluconazole treatment for this indication, particularly in cases of clinical failure. Objective The...
Alternative Titles
Full title
Cost and Resource Utilization Associated With Fluconazole as First-Line Therapy for Invasive Candidiasis: A Retrospective Database Analysis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_854375499
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_854375499
Other Identifiers
ISSN
0149-2918
E-ISSN
1879-114X
DOI
10.1016/j.clinthera.2011.01.001
